The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation.
about
Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation.Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir.Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients.Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.Valganciclovir: therapeutic role in pediatric solid organ transplant recipients.Prevention of cytomegalovirus following solid organ transplantation: a literature review.Virus-specific T-cell therapy in solid organ transplantation.A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients.Current prevention strategies against cytomegalovirus in the studies in pediatric liver transplantation (SPLIT) centers.Cytomegalovirus Infection under a Hybrid Strategy in Pediatric Liver Transplantation: A Single-Center Experience.
P2860
Q35196219-82FA0388-F827-4007-9F27-C14FB70698B4Q35785403-1ACE1261-CC66-4679-86C6-D0A7169EDC19Q36288594-94C3DF60-F90F-484D-952E-ED6724991143Q37825594-1FA62308-24BC-4F18-9BB1-7CD2C9378CF1Q38087371-12E03DAE-472F-494B-97E7-4F346433ACB2Q38124439-E283F56D-3E72-48C4-911B-385EDFF3822DQ38568902-8802B5AC-5EA4-40A4-A53C-7C46FF81D6A2Q38938297-90F19B1F-FDB7-4385-A8D2-760ED77A8A6BQ40353704-E42A77BD-03D4-4002-90C3-F4DF2F7E17A2Q42211907-2C5A765F-60A7-458C-A8BC-C616654512E9Q42261599-892092F8-D1AA-4591-974A-63861B9A47F2
P2860
The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The efficacy and safety of val ...... r solid organ transplantation.
@en
The efficacy and safety of val ...... r solid organ transplantation.
@nl
type
label
The efficacy and safety of val ...... r solid organ transplantation.
@en
The efficacy and safety of val ...... r solid organ transplantation.
@nl
prefLabel
The efficacy and safety of val ...... r solid organ transplantation.
@en
The efficacy and safety of val ...... r solid organ transplantation.
@nl
P2093
P2860
P1476
The efficacy and safety of val ...... er solid organ transplantation
@en
P2093
P2860
P304
P356
10.1111/J.1399-3046.2010.01330.X
P577
2010-05-03T00:00:00Z